Epidemiology and prevention of pancreatic cancer

Japanese Journal of Clinical Oncology

Volumn 34, Issue 5, 2004, Pages 238-244

  Lowenfels, Albert B ^a   Maisonneuve, Patrick ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Epidemiology; Genetics; Pancreatic cancer; Risk factors; Smoking

Indexed keywords

ACETYLSALICYLIC ACID; BRCA2 PROTEIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; DIETARY INTAKE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; HUMAN; JAPAN; OCCUPATIONAL EXPOSURE; ONSET AGE; PANCREAS CANCER; PANCREATITIS; PUBLIC HEALTH; RACE; RISK FACTOR; SMOKING; UNITED STATES; AGED; DIET; FEMALE; GENETICS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; REVIEW; TUMOR SUPPRESSOR GENE;

AGED; DIET; FEMALE; GENES, BRCA2; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK FACTORS; SMOKING; UNITED STATES;

EID: 3342997700     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh045     Document Type: Article

References (67)

1. Parkin DM, Muir C, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents. IARC Scientific Publications No. 120, 1992;1-1033.
2. SEER Cancer Statistics Review, 1975-2003. http://Seer.gov/csr/1975-2000. 2003.
3. Pernick NL, Sarkar FH, Philip PA, Arlauskas P, Shields AF, Vaitkevicius VK, et al. Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians. Pancreas 2003;26:28-32.
4. Dong M, Nio Y, Tamura K, Song MM, Guo KJ, Guo RX, et al. Ki-ras point mutation and p53 expression in human pancreatic cancer: A comparative study among Chinese, Japanese, and Western patients. Cancer Epidemiol Biomarkers Prev 2000;9:279-84.
5. Song MM, Nio Y, Dong M, Tamura K, Furuse K, Tian YL, et al. Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients. J Surg Oncol 2000;75: 176-85.
6. Longnecker DS, Karagas MR, Tosteson TD, Mott LA. Racial differences in pancreatic cancer: Comparison of survival and histologic types of pancreatic carcinoma in Asians, blacks, and whites in the United States. Pancreas 2000;21:338-43.
7. Mulder I, Hoogenveen RT, van Genugten ML, Lankisch PG, Lowenfels AB, de Hollander AE, et al. Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union. Eur J Gastroenterol Hepatol 2002;14:1343-53.
8. Silverman DT, Dunn JA, Hoover RN, Schiffman M, Lillemoe KD, Schoenberg JB, et al. Cigarette smoking and pancreas cancer: A case-control study based on direct interviews. J Natl Cancer Inst 1994;86: 1510-6.
9. Mack TM, Yu MC, Hanisch R, Henderson BE. Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 1986;76:49-60.
10. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors [see comments]. Br Med J 1994;309:901-11.
11. Lin Y, Tamakoshi A, Kawamura T, Inaba Y, Kikuchi S, Motohashi Y, et al. A prospective cohort study of cigarette smoking and pancreatic cancer in Japan. Cancer Causes Control 2002;13:249-54.
12. Akiba S, Hirayama T. Cigarette smoking and cancer mortality risk in Japanese men and women-results from reanalysis of the six-prefecture cohort study data. Environ Health Perspect 1990;87:19-26.
13. Rothman KJ. Modern Epidemiology. Boston: Little Brown, 1986:285-310.
14. Baghurst PA, McMichael AJ, Slavotinek AH, Baghurst KI, Boyle P, Walker AM. A case-control study of diet and cancer of the pancreas. Am J Epidemiol 1991;134:167-79.
15. Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, Runia S. Intake of foods and nutrients and cancer of the exocrine pancreas: A population-based case-control study in the Netherlands. Int J Cancer 1991;48:540-9.
16. Ghadirian P, Simard A, Baillargeon J, Maisonneuve P, Boyle P. Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int J Cancer 1991;47:1-6.
17. Ghadirian P, Thouez JP, PetitClerc C. International comparisons of nutrition and mortality from pancreatic cancer. Cancer Detect Prev 1991;15: 357-62.
18. Zatonski W, Przewozniak K, Howe GR, Maisonneuve P, Walker AM, Boyle P. Nutritional factors and pancreatic cancer: A case-control study from south-west Poland. Int J Cancer 1991;48:390-4.
19. Rautalahti MT, Virtamo JR, Taylor PR, Heinonen OP, Albanes D, Haukka JK, et al. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. Cancer 1999;86:37-42.
20. Potter JD. Pancreas cancer-we know about smoking, but do we know anything else? Am J Epidemiol 2002;155:793-5.
21. Howe GR, Ghadirian P, Bueno de Mesquita HB, Zatonski W, Baghurst PA, Miller AB, et al. A collaborative case-control study of nutrient intake and pancreatic cancer within the SEARCH programme. Int J Cancer 1992;51:365-72.
22. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 2002;155:783-92.
23. Ohba S, Nishi M, Miyake H. Eating habits and pancreas cancer. Int J Pancreatol 1996;20:37-42.
24. Lee IM, Sesso HD, Oguma Y, Paffenbarger RS Jr. Physical activity, body weight, and pancreatic cancer mortality. Br J Cancer 2003;88:679-83.
25. Ye W, Lagergren J, Weiderpass E, Nyren O, Adami HO, Ekbom A. Alcohol abuse and the risk of pancreatic cancer. Gut 2002;51:236-9.
26. Ojajarvi A, Partanen T, Ahlbom A, Boffetta P, Hakulinen T, Jourenkova N, et al. Risk of pancreatic cancer in workers exposed to chlorinated hydrocarbon solvents and related compounds: A meta-analysis. Am J Epidemiol 2001;153:841-50.
27. Collins JJ, Esmen NA, Hall TA. A review and meta-analysis of formaldehyde exposure and pancreatic cancer. Am J Ind Med 2001;39:336-45.
28. McCallion K, Mitchell RM, Wilson RH, Kee F, Watson RG, Collins JS, et al. Flexible sigmoidoscopy and the changing distribution of colorectal cancer: Implications for screening. Gut 2001;48:522-5.
29. Kauppinen T, Partanen T, Degerth R, Ojajarvi A. Pancreatic cancer and occupational exposures. Epidemiology 1995;6:498-502.
30. Alguacil J, Kauppinen T, Porta M, Partanen T, Malats N, Kogevinas M, et al. Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group. Ann Occup Hyg 2000;44:391-403.
31. Hoppin JA, Tolbert PE, Holly EA, Brock JW, Korrick SA, Altshul LM, et al. Pancreatic cancer and serum organochlorine levels. Cancer Epidemiol Biomarkers Prev 2000;9:199-205.
32. Porta M, Malats N, Jariod M, Grimalt JO, Rifa J, Carrato A, et al. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. Lancet 1999;354: 2125-9.
33. Fryzek JP, Garabrant DH, Harlow SD, Severson RK, Gillespie BW, Schenk M, et al. A case-control study of self-reported exposures to pesticides and pancreas cancer in southeastern Michigan. Int J Cancer 1997; 72:62-7.
34. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993;328:1433-7.
35. Lowenfels AB, Maisonneuve P, DiMagno EP, Elitsur Y, Gates LKJ, Perrault J, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997;89:442-6.
36. Chari ST, Mohan V, Pitchumoni CS, Viswanathan M, Madanagopalan N, Lowenfels AB. Risk of pancreatic carcinoma in tropical calcifying pancreatitis: An epidemiologic study. Pancreas 1994;9:62-6.
37. Bansal P, Sonnenberg A. Comorbid occurrence of cholelithiasis and gastrointestinal cancer. Eur J Gastroenterol Hepatol 1996;8:985-8.
38. Bueno-de-Mesquita HB, Maisonneuve P, Moerman CJ, Walker AM. Aspects of medical history and exocrine carcinoma of the pancreas: A population-based case-control study in The Netherlands. Int J Cancer 1992;52:17-23.
39. Chow WH, Johansen C, Gridley G, Mellemkjaer L, Olsen JH, Fraumeni JF Jr. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer 1999;79:640-4.
40. Coughlin SS, Calle EE, Patel AV, Thun MJ. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000;11:915-23.
41. Hedberg M, Ogren M, Janzon L, Sternby NH. Pancreatic carcinoma following gastric resection. A case-control study based on 21,660 consecutive clinical necropsies at Malmo University Hospital. Int J Pancreatol 1997;21:219-24.
42. Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-7.
43. Tascilar M, van Rees BP, Sturm PD, Tytgat GN, Hruban RH, Goodman SN, et al. Pancreatic cancer after remote peptic ulcer surgery. J Clin Pathol 2002;55:340-5.
44. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. J Am Med Assoc 1995;273:1605-9.
45. Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod SA, et al. Inherited predisposition to pancreatic adenocarcinoma: Role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 2000;60: 409-16.
46. Kern SE, Hruban RH, Hidalgo M, Yeo CJ. An introduction to pancreatic adenocarcinoma genetics, pathology and therapy. Cancer Biol Ther 2002; 1:607-13.
47. Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM, DiMagno EP. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. J Am Med Assoc 2001;286:169-70.
48. Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 2003;124:1292-9.
49. Durie P, Lerch MM, Lowenfels, AB, Maisonneuve P, Ulrich CD, Whitcomb DC. Genetic Disorders of the Exocrine Pancreas. An Overview and Update. Basel: Karger, 2002.
50. Kokawa A, Kondo H, Gotoda T, Ono H, Saito D, Nakadaira S, et al. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer 2001;91:333-8.
51. Anderson KE, Johnson TW, Lazovich D, Folsom AR. Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst 2002;94:1168-71.
52. Kakizoe T, editor. Cancer Statistics in Japan - 2001. Japan National Cancer Center. 2002. Foundation for Promotion of Cancer Research, Tokyo, Japan.
53. Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001;7:738-44.
54. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85.
55. Hammel PR, Vilgrain V, Terris B, Penfornis A, Sauvanet A, Correas JM, et al. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie devon Hippel-Lindau. Gastroenterology 2000;119:1087-95.
56. Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR, Brentnall TA. Inherited predisposition to pancreatic cancer. Gut 2001;48:143-7.
57. Vasen HF, Gruis NA, Frants RR, Der Velden PA, Hille ET, Bergman W. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000;87:809-111.
58. Murphy KM, Brune KA, Griffin C, Sollenberger JE, Petersen GM, Bansal R, et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: Deleterious BRCA2 mutations in 17%. Cancer Res 2002;62:3789-93.
59. Su GH, Hruban RH, Bansal M Bova GS, Tang DJ, Shekher MC, et al. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999;154:1835-40.
60. Maisonneuve P, FitzSimmons SC, Neglia JP, Campbell PW III, Lowenfels AB. Cancer risk in nontransplanted and transplanted cystic fibrosis patients: A 10-year study. J Natl Cancer Inst 2003;95:381-7.
61. Neglia JP, FitzSimmons SC, Maisonneuve P, Schoni MH, Schoni-Affolter F, Corey M, et al. The risk of cancer among patients with cystic fibrosis. N Engl J Med 1995;332:494-9.
62. Ghadirian P, Lynch HT, Krewski D. Epidemiology of pancreatic cancer: An overview. Cancer Detect Prev 2003;27:87-93.
63. van der Heijden MS, Yeo CJ, Hruban RH, Kern SE. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 2003;63:2585-8.
64. Foster JR, Idle JR, Hardwick JP, Bars R, Scott P, Braganza JM. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol 1993;169:457-63.
65. Duell EJ, Holly EA, Bracci PM, Liu M, et al. A population-based case-control study of polymorphisms in carcinogen-metabolizing genes, smoking and pancreatic adenocarcinoma risk. J Natl Cancer Inst 2002;94:297-306.
66. Bartsch H, Malaveille C, Lowenfels AB, Maisonneuve P, Hautefeuille A, Boyle P. Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:qUinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group. Eur. J Cancer Prev 1998;7:215-23.
67. Ockenga J, Vogel A, Teich N, Keim V, Manus MP, Strassburg CP. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 2003;124: 1802-8.